Prognostic factors for post-recurrence survival in patients with completely resected stage I non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 2, 2014, Pages 262-267

  Song, In Hag ^a,c   Yeom, Sung Won ^a   Heo, Seohee ^a   Choi, Won Suk ^a   Yang, Hee Chul ^a   Jheon, Sanghoon ^a,b   Kim, Kwhanmien ^a,b   Cho, Sukki ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

Non small cell lung cancer; Post recurrence survival; Recurrence; Stage I

Indexed keywords

PROTEIN TYROSINE KINASE INHIBITOR; TUMOR MARKER;

ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRANIOTOMY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHRECTOMY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; TREATMENT RESPONSE; VERY ELDERLY; WEDGE RESECTION;

NON-SMALL-CELL LUNG CANCER; POST-RECURRENCE SURVIVAL; RECURRENCE; STAGE I;

AGED; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES;

EID: 84892501859     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt333     Document Type: Article

References (20)

1. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-92.
2. Scott WJ, Howington J, Feigenberg S, Movsas B, Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:234S-42.
3. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7.
4. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.
5. Harpole DH Jr, Herndon JE 2nd, Young WG Jr, Wolfe WG, Sabiston DC Jr. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-96.
6. Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR. Stage IB nonsmall cell lung cancers: are they all the same?. Ann Thorac Surg 2006;81:1958-62.
7. Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K. Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2008;34:499-504.
8. al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg 1997;12:380-4.
9. Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS et al. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009;64:192-6.
10. Hung JJ, Jeng WJ, Hsu WH, Wu KJ, Chou TY, Hsieh CC et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax 2010;65:241-5.
11. Virgo KS, McKirgan LW, Caputo MC, Mahurin DM, Chao LC, Caputo NA et al. Post-treatment management options for patients with lung cancer. Ann Surg 1995;222:700-10.
12. Walsh GL, O'Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995;60:1563-70.
13. Younes RN, Gross JL, Deheinzelin D. Follow-up in lung cancer: how often and for what purpose? Chest 1999;115:1494-9.
14. Bennett JJ, Gonen M, D'Angelica M, Jaques DP, Brennan MF, Coit DG. Is detection of asymptomatic recurrence after curative resection associated with improved survival in patients with gastric cancer?. J Am Coll Surg 2005;201:503-10.
15. Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg 2007;83:409-17.
16. Voltolini L, Paladini P, Luzzi L, Ghiribelli C, Di Bisceglie M, Gotti G. Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma. Eur J Cardiothorac Surg 2000;18:529-34.
17. Williams BA, Sugimura H, Endo C, Nichols FC, Cassivi SD, Allen MS et al. Predicting postrecurrence survival among completely resected nonsmallcell lung cancer patients. Ann Thorac Surg 2006;81:1021-7.
18. Choi SH, Kim YT, Kim SK, Kang KW, Goo JM, Kang CH et al. Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer. Ann Thorac Surg 2011;92:1826-32.
19. Cho S, Lee EB. A follow-up of integrated positron emission tomography/ computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients. J Thorac Cardiovasc Surg 2010;139:1447-51.
20. Yoshino I, Yohena T, Kitajima M, Ushijima C, Nishioka K, Ichinose Y et al. Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann Thorac Cardiovasc Surg 2001;7:204-9.